Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients
ELESDUCCBM
Long-term Evaluation of the Efficacy and Safety of a Continent Cutaneous Urinary Diversion in Spinal Cord Injury Patients
1 other identifier
observational
70
1 country
1
Brief Summary
Continent Cutaneous Urinary Deviation (CUD), using the Mitrofanoff, Yang-Monti or Casale principle, is offered to patients with neurological diseases who are unable to perform intermittent catheterisation through the native urethra due to upper limb disability. There is very little data in the literature examining the long-term efficacy and complications of this technique. The main objective of this study is to evaluate the effectiveness of long-term CUDs in spinal cord injury patients. The secondary objectives are to evaluate the surgical complications and the impact on the patient's quality of life. For each patient, several data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly and any immediate or late complications. In a second stage, a questionnaire survey will be conducted by telephone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 18, 2021
CompletedFirst Posted
Study publicly available on registry
June 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedSeptember 28, 2022
September 1, 2022
2.4 years
June 18, 2021
September 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Efficacy of continent cutaneous urinary derivation: catheterisation.
The minimum frequency of urinary catheterisation in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
3 -16 years after their operation
Efficacy of continent cutaneous urinary derivation:leakage
Absence of leakage through the cystostomy in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.
3 -16 years after their operation
Secondary Outcomes (13)
Surgical complications and impact on the patient's quality of life: Age at start of care
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: Sex
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: Body Mass Index
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: ASA score
3 -16 years after their operation
Surgical complications and impact on the patient's quality of life: ASIA score
3 -16 years after their operation
- +8 more secondary outcomes
Study Arms (1)
Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017
The study focuses of a population of 70 patients operated between April 2004 and October 2017 au Nîmes University Hospital for Cutaneous Urinary Diversion.
Interventions
For each patient, the following data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly, immediate and later complications.
A telephone survey will be conducted by means of a questionnaire in order to evaluate the patient's quality of life.
Eligibility Criteria
All patients who have suffered a spinal cord injury, operated on between April 2004 and October 2017 at Nîmes University Hospital.
You may qualify if:
- no history of continuous cystostomy in another centre
- a follow-up \> 24 months,
- a continent cutaneous urinary diversion for a spinal cord injury.
- Patient affiliated to or beneficiary of a health insurance scheme.
- Adult patient (≥18 years of age) and under 85 years of age.
You may not qualify if:
- All urinary incontinence outside of medullary waiting period.
- A history of continuous cystostomy in another centre.
- A follow-up of less than 24 months,
- a continent cutaneous urinary diversion for a neurological pathology other than spinal cord injury.
- Patient for whom it is impossible to give enlightened information.
- Patient under legal protection, guardianship or curatorship.
- Patient unable to express consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nîmes University Hospital
Nîmes, Gard, 30029, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2021
First Posted
June 23, 2021
Study Start
August 1, 2020
Primary Completion
January 1, 2023
Study Completion
June 1, 2023
Last Updated
September 28, 2022
Record last verified: 2022-09